附註:Includes bibliographical references (pages 382-385) and index.
Book Cover; Title; Contents; Preface; Acknowledgements; Contributors; Achieving optimal blood pressure control; Regression of left ventricular hypertrophy; Cholesterol and coronary heart disease: the current status; Hormone replacement therapy and cardiovascular disease: are the cardiovascular benefits established?; Alcohol, hypertension and cardiovascular disease; Diabetes and the heart; Inflammation and infection in coronary artery disease; Unstable coronary syndromes: what is new?; Myocardial stunning; Ischemic preconditioning: from bench to bedside.
The role of ACE inhibitors in coronary artery diseaseAngiotensin receptor blockers for chronic heart failure and acute myocardial infarction; Cardiovascular disease in the elderly; Laser myocardial revascularization; Vascular brachytherapy; Syndrome X; Genetics in cardiovascular disease; Cardiac rehabilitation; New thoughts in antiarrhythmic therapy; Index.
摘要:At nearly every cardiology conference, whether in Europe or in the U.S., new clinical trial data is published. At times, so much information is published that the busy clinical cardiologist does not have time to keep abreast of the latest and preferred therapies. This successive volume examines advances that have taken place since the previous version, and it explores various therapeutic options for the cardiovascular patient and the cost implications for the hospital. Topics in this latest edition include blood pressure control, transmyocardial revascularization, endothelial dysfunction and t.
